22.03.2010

Deinobiotics, project led by Deinove in partnership with biotech company Nosopharm and two expert laboratories, CPBS (CNRS - University of Montpellier 1) and IGS (CNRS Marseille), was labelled by the Eurobiomed pole and has been selected for funding under the 9th call for projects of the FrenchCompetitiveness Clusters. Deinobiotics is aimed at screening the antibiotic and antifungal potential of Deinove's unique microbial library and at developing new molecules for treating resistant microbial infections, a high-priority medical need. The objective of this programme is to deliver at least one or two new compounds at the pre-IND stage.